High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q41670609

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

High IDH1 expression is associ ...... normal acute myeloid leukemia.

@en

type

Item

label

High IDH1 expression is associ ...... normal acute myeloid leukemia.

@en

prefLabel

High IDH1 expression is associ ...... normal acute myeloid leukemia.

@en

P1476

High IDH1 expression is associ ...... normal acute myeloid leukemia.

@en

P2093

Chao Hu

http://www.w3.org/2001/XMLSchema#string

Dong-Mei Wang

http://www.w3.org/2001/XMLSchema#string

Fei-Fei Chen

http://www.w3.org/2001/XMLSchema#string

Jian Chen

http://www.w3.org/2001/XMLSchema#string

Jie Jin

http://www.w3.org/2001/XMLSchema#string

Jing-Han Wang

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Meng-Xia Yu

http://www.w3.org/2001/XMLSchema#string

Min Yang

http://www.w3.org/2001/XMLSchema#string

Qi-Tian Mu

http://www.w3.org/2001/XMLSchema#string

P2860

Recurring mutations found by sequencing an acute myeloid leukemia genome

Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.

Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

P304

1058-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29395

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25523507

http://www.w3.org/2001/XMLSchema#string